Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Explore how glide paths and passive retirement options work, including risk and cost differences. This intro helps you compare pros and cons before choosing a strategy.
26,696 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
As July opens, bitcoin nears final stage of its bear market window, with prices holding steady and institutional infl...
CFOs are increasingly moving into the CEO chair, but AI-driven disruption is testing how long they can stay. New data...
New home sales edged lower in December but remain near multiyear highs at 745,000 SAAR, driven by financing incentive...
Enterprise Products Partners closed 2025 with record cash flow and a steady ~6% yield, extending a 26-year payout str...
Southwest Gas missed Q4 earnings by three cents but reaffirmed its 14% annual growth target through 2030, tying the m...
Fairway Home Mortgage elevates Holly Mattson to co-president of recruiting to accelerate onboarding of loan producers...
Elon Musk took the stand in a Delaware court as Twitter shareholders pursue damages over pre-purchase disclosures. Th...
A 2024 submarine cable incident revealed Bitcoin’s resilience as researchers map how topology and redundancy protect ...
Micron Technology led a Tuesday rally in the memory sector, with peers posting solid gains as a new AMAT collaboratio...
XRP’s on-chain activity jumped to about 2.75 million daily transactions, while the token’s price stayed stubbornly ra...
The 2026 Farm Bill quietly expands AI and precision-agriculture subsidies while letting private tech firms set standa...